AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Total payout ratio

WAKAMOTO PHARMACEUTICAL CO.,LTD.【JP:4512】

Market cap
¥11.6B
P/E ratio
58x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal payout ratio (Million JPY)YoY (%)
Mar 31, 2025160.5+68.22%
Mar 31, 202495.4+23662.83%
Mar 31, 20230.4+71.00%
Mar 31, 20220.2-337.46%
Mar 31, 2021-0.1+141.54%
Mar 31, 2020-0-99.93%
Mar 31, 2019-57.2-167.11%
Mar 31, 201885.2-24.35%
Mar 31, 2017112.6-78.42%
Mar 31, 2016522.1+298.35%
Mar 31, 2015131.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)